FERRING PHARMACEUTICALS A/S: Financial statements 2021
CVR: 16313440
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
FERRING PHARMACEUTICALS A/S (CVR 16313440) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 1,005,468,000 and a net result of DKK 40,174,000 compared with DKK 40,928,000 the year before. That is a decrease of 4.4% compared with the year before. The profit margin was 4%. Equity in the 2021 report amounted to DKK 69,618,000. The solvency ratio was 14.7%. The company had 487 employees in the financial year.
- Revenue
- DKK 1,005,468,000
- Gross Profit
- DKK 1,005,468,000
- Profit/Loss
- DKK 40,174,000
- Equity
- DKK 69,618,000
- Total Assets
- DKK 472,880,000
- Employees
- 487
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 1B | 1B | 40.2M | 69.6M | 487 |
| 2020 | 1.1B | 1.1B | 40.9M | 79.4M | 497 |
| 2019 | 1.4B | 1.4B | 38.3M | 106.5M | 533 |
| 2018 | 1.4B | 1.4B | 56.1M | 118.2M | 525 |
| 2017 | 1.3B | 1.3B | 54.7M | 112.1M | 548 |
Official annual report
Find more companies like FERRING PHARMACEUTICALS A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 10, 2021, Marianne Kock has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Per Gunnar Falk has joined the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Ole Kjerulf-Jensen has left the board of directors of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Bolette Wildt is registered as director of FERRING PHARMACEUTICALS A/S.
As of December 10, 2021, Kim Fonager Jensen is registered as director of FERRING PHARMACEUTICALS A/S.
As of December 9, 2021, Per Gunnar Falk has left the board of directors of FERRING PHARMACEUTICALS A/S.
FERRING PHARMACEUTICALS A/S has published its annual report for 2020. Revenue came to DKK 1,051,468,000, and the net result was DKK 40,928,000.
About FERRING PHARMACEUTICALS A/S
FERRING PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Kastrup, founded in 1992. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named FERRING NORDIC PHARMACEUTICALS A/S and A/S PSE 38 NR. 1587. The management consists of Jan Peutzfeldt, Ingbritt Tolstrup Birk and Jesper Thomsen. The board consists of Marianne Kock (chair), Dag Frederik Arfst Paulsen and Jean-Frederic Paulsen. The company is owned by Ferring B.V.. The company has 522 employees (2026). In 2025, the company reported revenue of DKK 1,730,413,000 and a net result of DKK 49,005,000 compared with DKK 76,890,000 the year before. Equity in the 2025 report amounted to DKK 315,220,000.